The two companies have already been working together for two years and have developed the first technological building blocks for medical diagnosis and prognosis solutions. This partnership adds a new dimension to existing synergies.
Talan and AiiNTENSE will develop technological solutions, based on artificial intelligencein order to provide the essential decision support tools in intensive care, with a focus on neurological pathologies. Beyond the multitude of structured data generated by the care tools, it is also the clinical observations (unstructured data) that enrich the information needed for collaborative medical decision-making between different specialists.
These solutions are a real revolution for to better assess the neurological condition of patients and make medical diagnosis more reliable in a shared environment. Indeed, thanks to cognitive decision support assistants, tele-expertise services and data collection in a single interface, they create a collaborative work environment focused on care and adapted to hospital needs. A real asset that allows better care and follow-up of patients.
These innovative and intuitive tools also provide better interoperability in the face of the heterogeneity of different hospital software solutions and the diversity of clinical observations. In the medium term, the Talan andAiiNTENSE teams will extend their developments to other medical disciplines and specialties. These comprehensive clinical data analysis solutions will enable rapid changes in practices for the benefit of patients and practitioners.
"We are very pleased to be partnering with AiiNTENSE to develop solutions that enable a more efficient and effective use of our resources. better care for patients admitted to the intensive care unit. The collaboration with Daniel Duhautbout and the medical teams ofAiiNTENSE, including Professor Tarek Sharshar of the GHU Paris Sainte-AnneThis is essential in order to develop operational solutions in their field of expertise and to consider quickly taking them to other fields of application. "says Thibault Ducray, Managing Director of Talan Labs.
"We are proud to have participated in this meaningful project. This is a great human adventure where everyone has put their technical expertise and its creativity for the well-being of patients. "states Sami Khalfaoui, Director of Innovation at Talan Labs.
"To benefit from theTalan's business and technological expertise is a valuable asset for AiiNTENSE. In combining our expertise with that of TalanThis allows us to deploy innovative solutions, based on interoperability between medical solutions, the data cycle, the cloud and artificial intelligence, in order toimprove the management of patients in intensive care. "states Daniel Duhautbout, CEO ofAiiNTENSE.
For more than 15 years, Talan has been advising companies and administrations, supporting them and implementing their transformation projects in France and abroad. With a presence on five continents, the group aims to generate €350 million for 3,500 consultants by 2021 and to exceed €1 billion in turnover by 2024. The group places innovation at the heart of its development and operates in areas linked to the technological changes of large groups, such as Big Data, IoT, Blockchain and Artificial Intelligence.
AiiNTENSE is a start-up created in Ile-de-France in October 2018, co-incubated by Genopole and IMT Starter, and accelerated by Voisin Consulting Life Science, EIT Health and the Nice Côte d'Azur Metropolis. AiiNTENSE received the Deloitte Coup de Coeur Award at the CES in Las Vegas as part of the Bercy-IMT Innovation Prize with the Mines Telecom Foundation. AiiNTENSE develops technological and medical solutions for cognitive assistance for neurologists and intensive care units in hospitals and clinics in order to improve the medical, economic and ethical care of patients.